MKS (NASDAQ:MKSI) Price Target Raised to $355.00 at Citigroup

MKS (NASDAQ:MKSI) had its target price hoisted by equities researchers at Citigroup from $290.00 to $355.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the scientific and technical instruments company’s stock. Citigroup’s price target points to a potential upside of 13.46% from the company’s previous close.

MKSI has been the topic of a number of other reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $380.00 price target on shares of MKS in a research report on Friday. Mizuho set a $320.00 price target on shares of MKS in a research report on Thursday, February 19th. JPMorgan Chase & Co. boosted their price target on shares of MKS from $305.00 to $365.00 and gave the company an “overweight” rating in a research report on Friday. Morgan Stanley restated an “overweight” rating and issued a $354.00 price target on shares of MKS in a research report on Thursday. Finally, Bank of America boosted their price target on shares of MKS from $215.00 to $255.00 and gave the company a “buy” rating in a research report on Thursday, January 22nd. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, MKS presently has an average rating of “Moderate Buy” and a consensus price target of $317.23.

MKS Price Performance

NASDAQ:MKSI traded up $12.10 on Friday, reaching $312.89. The stock had a trading volume of 1,452,178 shares, compared to its average volume of 1,413,504. The company has a market capitalization of $21.06 billion, a P/E ratio of 65.46, a price-to-earnings-growth ratio of 1.57 and a beta of 1.98. MKS has a 1-year low of $78.62 and a 1-year high of $326.83. The company has a quick ratio of 1.71, a current ratio of 2.71 and a debt-to-equity ratio of 1.53. The stock has a fifty day moving average price of $249.12 and a 200-day moving average price of $205.60.

MKS (NASDAQ:MKSI) last released its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $2.30 EPS for the quarter, beating analysts’ consensus estimates of $2.00 by $0.30. The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. MKS had a net margin of 8.06% and a return on equity of 21.88%. The company’s revenue for the quarter was up 15.2% compared to the same quarter last year. During the same period in the previous year, the business earned $1.71 earnings per share. MKS has set its Q2 2026 guidance at 2.600-3.200 EPS. Research analysts forecast that MKS will post 9.89 EPS for the current year.

Insider Activity at MKS

In other news, EVP Eric Robert Taranto sold 4,568 shares of the company’s stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $220.52, for a total transaction of $1,007,335.36. Following the transaction, the executive vice president directly owned 15,445 shares in the company, valued at approximately $3,405,931.40. This represents a 22.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO John Tseng-Chung Lee sold 30,000 shares of the company’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $256.77, for a total transaction of $7,703,100.00. Following the transaction, the chief executive officer owned 154,696 shares in the company, valued at $39,721,291.92. The trade was a 16.24% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 68,503 shares of company stock valued at $17,288,099 in the last three months. 0.57% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On MKS

Large investors have recently modified their holdings of the stock. Vanguard Group Inc. raised its stake in shares of MKS by 4.0% during the third quarter. Vanguard Group Inc. now owns 7,752,097 shares of the scientific and technical instruments company’s stock worth $959,477,000 after buying an additional 295,480 shares during the last quarter. Cooke & Bieler LP raised its stake in shares of MKS by 7.7% during the third quarter. Cooke & Bieler LP now owns 1,321,877 shares of the scientific and technical instruments company’s stock worth $163,609,000 after buying an additional 94,692 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of MKS by 30.8% during the third quarter. Dimensional Fund Advisors LP now owns 1,265,365 shares of the scientific and technical instruments company’s stock worth $156,602,000 after buying an additional 297,850 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of MKS by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 1,254,049 shares of the scientific and technical instruments company’s stock worth $200,438,000 after buying an additional 5,551 shares during the last quarter. Finally, Bank of America Corp DE raised its stake in shares of MKS by 44.2% during the second quarter. Bank of America Corp DE now owns 982,643 shares of the scientific and technical instruments company’s stock worth $97,635,000 after buying an additional 301,223 shares during the last quarter. 99.79% of the stock is currently owned by institutional investors and hedge funds.

More MKS News

Here are the key news stories impacting MKS this week:

• Positive Sentiment: Q1 results and raised guidance: MKS reported Q1 EPS of $2.30 (vs. $2.00 est.) and revenue of $1.08B (vs. $1.05B est.), and issued Q2 EPS guidance of $2.60–3.20 and revenue guidance around $1.2B — all above Street expectations, supporting the stock’s rally. GlobeNewswire: Q1 Results
• Positive Sentiment: Needham raised its price target to $360 and maintained a “buy” rating, signaling analyst confidence in upside from continued semiconductor/AI-driven demand. Street Insider: Needham PT Raise
• Positive Sentiment: JPMorgan raised its target to $365 and put an “overweight” rating on MKSI, providing another high‑profile vote of confidence that likely contributed to buying interest. Benzinga: JPMorgan PT Raise
• Neutral Sentiment: Earnings call transcript available — useful for parsing management commentary on AI-related demand, supply chain, and margin drivers to judge sustainability of the beat. Seeking Alpha: Q1 Call Transcript
• Neutral Sentiment: Analysts (Zacks and others) highlight that strength was driven by AI-related demand across semiconductor markets — a positive thematic driver but one that requires monitoring for cyclicality. Zacks: Earnings Beat Coverage
• Negative Sentiment: Wells Fargo raised its target to $300 but kept an “equal weight” rating — the PT implies modest downside vs. recent levels, signaling some analysts view limited near‑term upside and suggesting potential caution/price consolidation. Benzinga: Wells Fargo PT Raise

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.